The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
Paul A. Spagnuolo(University of Guelph), Aaron D. Schimmer(University of Toronto), Reza Beheshti Zavareh(Ontario Institute for Cancer Research), Ashley Di Meo(University Health Network), Mahadeo A. Sukhai(Princess Margaret Cancer Centre), Sumaiya Sharmeen(Ontario Institute for Cancer Research), Craig D. Simpson(University of Toronto), Iman Ashali(Ontario Institute for Cancer Research), Marcela Gronda(Ontario Institute for Cancer Research), Jonathan Boss(Ontario Institute for Cancer Research), Robert Rottapel(Ontario Institute for Cancer Research), Xiaoming Wang(Nanjing Drum Tower Hospital), Noah Fine(University Health Network), Jiayi Hu(Ontario Institute for Cancer Research), Rose Hurren(Ontario Institute for Cancer Research)
Cited by 149
Related Papers
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
Quasi-monoenergetic laser-plasma acceleration of electrons to 2 GeV
|Nature Communications|2013|641
1,3,4-Thiadiazole: Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry
|Chemical Reviews|2014|594
Carbon quantum dots: Preparation, optical properties, and biomedical applications
|Materials Today Advances|2023|367